Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in South Africa, Europe and North America. The aim of this trial is
to compare efficacy and safety of NN1250 (insulin degludec (IDeg)) with insulin glargine
(IGlar), as add-on to subject's ongoing treatment with metformin and/or dipeptyl peptidase 4
(DPP-4) inhibitors, in patients with type 2 diabetes being treated with oral anti-diabetic
drugs (OADs) qualifying for intensified treatment.